Citicoline Dosage: How Much to Take for Brain Health

Home > Learn > Citicoline Dosage

Citicoline, also called CDP-choline (cytidine diphosphate choline), is a naturally occurring compound in the brain and one of the more thoroughly studied cognitive supplements available. Unlike many nootropics backed by limited evidence, citicoline has been the subject of Cochrane reviews, multiple randomized controlled trials, and over three decades of clinical research. The question is not whether it works at all, it is what dose is appropriate for your goal.

What Is Citicoline and How Does It Work?

Citicoline is an intermediate in the synthesis of phosphatidylcholine, the primary phospholipid in cell membranes. When you take citicoline orally, it breaks down in the gut into choline and cytidine. Both cross the blood-brain barrier. In the brain, they recombine to support three key processes.

First, phosphatidylcholine synthesis. Cell membranes are largely composed of phosphatidylcholine, and membrane integrity determines how efficiently neurons signal each other. Citicoline provides the raw materials to maintain and repair neuronal membranes, relevant particularly in aging, when membrane composition naturally degrades.

Second, acetylcholine production. Choline is the direct precursor to acetylcholine, the neurotransmitter associated with memory formation, learning, and attention. Low acetylcholine activity is a hallmark of Alzheimer’s disease. Providing choline via citicoline supports acetylcholine synthesis in cholinergic neurons.

Third, dopamine and norepinephrine support. Citicoline appears to increase the density of dopamine receptors and has been shown to elevate dopamine and norepinephrine levels in animal models. This mechanism may explain the attention and motivation effects reported in some human trials, separate from the acetylcholine pathway.

A 2024 review in the FASEB Journal (PMID 39221499) synthesizes citicoline’s mechanisms in neuroinflammatory disorders, noting that citicoline also modulates the phospholipase A2 pathway, reducing the release of pro-inflammatory arachidonic acid from cell membranes, a neuroprotective action relevant to several neurological conditions.

Clinical Evidence by Application

Memory in Older Adults

The most directly relevant trial for healthy adults is Spiers et al. (1996) (PMID 8624220), which enrolled 95 older adults (average age 65) with age-associated memory impairment. Participants received 1,000 mg of citicoline per day for 12 weeks. The citicoline group showed significantly improved performance on verbal memory tests compared to placebo.

This established two things: First, citicoline can produce measurable cognitive benefits in non-demented aging adults. Second, the benefit is detectable on objective testing, not just subjective self-report.

Effective dose from this trial: 1,000 mg per day for 12 weeks.

Attention in Healthy Middle-Aged Adults

A 28-day randomized trial in healthy middle-aged women (average age 44) tested citicoline at 250 mg and 500 mg daily versus placebo. Both citicoline groups showed improved attention accuracy compared to placebo on the Continuous Performance Test, a computerized measure of sustained attention. The 250 mg group and 500 mg group produced comparable improvements, suggesting that lower doses in the healthy adult range may be sufficient.

Effective dose: 250–500 mg per day for 4 weeks.

Alzheimer’s Disease: Adjunct Use

A 2020 systematic review by Piamonte et al. (PMID 32538854) examined nine clinical trials of citicoline as an adjunct to Alzheimer’s treatment. The review found that citicoline, when added to standard acetylcholinesterase inhibitor therapy, was associated with cognitive improvements or stabilization compared to medication alone. The trials that showed meaningful benefit generally used 1,000 mg daily for 9–12 months.

This is important context: citicoline’s benefit in Alzheimer’s disease is as an adjunct, not a standalone treatment. It does not replace medication. However, as a complementary approach to supporting cholinergic function, the evidence is reasonably consistent.

Effective dose in this context: 1,000 mg per day for 9–12 months (always under medical supervision).

Chronic Cerebral Disorders: Cochrane Review Evidence

The most rigorous synthesis of citicoline’s clinical data is the Cochrane review by Fioravanti and Yanagi (PMID 15106147), which examined 14 randomized controlled trials of citicoline in patients with chronic cerebral disorders (including vascular dementia, cognitive impairment after stroke, and Parkinson’s disease). The review found consistent improvements in memory, attention, and behavioral function across the included trials. An earlier version of this same Cochrane review (PMID 11034681) reached similar conclusions, establishing the durability of this finding across review periods.

The authors noted that while the evidence was consistent, the trials were generally small and some had industry sponsorship, standard limitations acknowledged in Cochrane reviews.

Stroke and Traumatic Brain Injury: The Contradictory Story

This is where the evidence gets complicated. Early smaller studies of citicoline in stroke recovery showed promising results. These trials, many of which were conducted in the 1980s and 1990s, generated considerable optimism. But later, large-scale trials, including the ICTUS trial, one of the most rigorous studies, did not replicate the stroke recovery benefit.

The honest summary: citicoline cannot currently be recommended for stroke recovery based on the current evidence base. Early small trials were not confirmed by adequately powered later research. This is a common pattern in stroke pharmacology research and is not unique to citicoline.

For cognitive support in non-stroke populations, the stroke controversy does not invalidate the evidence.

Dosage Guide by Goal

EFSA guidance: The European Food Safety Authority recommends a maximum of 500 mg per day for food supplements and up to 1,000 mg per day for medical foods in middle-aged to elderly populations. For most healthy adults, 250–500 mg daily is the appropriate range.

When to Take Citicoline

Citicoline is not a stimulant and does not produce acute effects analogous to caffeine. You will not feel it in the first hour. However, some users report that taking citicoline later in the day (afternoon or evening) disrupts sleep, a finding with some clinical backing. The Bracken et al. (2011) trial (PMID 21397626) examined citicoline’s effects on sleep architecture in cocaine-dependent adults (using citicoline as a recovery intervention) and found that eight weeks of citicoline treatment did not perturb normal sleep-wake cycles, but this was in a clinical population under supervised conditions.

Practical guidance:

• Take citicoline in the morning or early afternoon for best tolerability
• Take with or without food, absorption is not significantly affected by food
• Consistent daily timing improves compliance; the cognitive effects of citicoline accumulate with consistent use, not single doses
• Some users split the dose (e.g., 250 mg morning, 250 mg early afternoon) to maintain sustained choline availability throughout the day

Citicoline vs. Other Choline Sources

Citicoline is not the only way to supplement choline. Understanding how it compares helps clarify whether it is the right choice.

Alpha-GPC: Provides choline with a glycerophosphate backbone. Often compared to citicoline as a nootropic. Alpha-GPC delivers choline efficiently and may raise acetylcholine levels more acutely, which is why it appears in some pre-workout and fast-acting cognitive formulas. It does not supply cytidine, so it does not support the full phosphatidylcholine synthesis pathway that citicoline does.

Choline bitartrate: The cheapest form, widely available. Provides choline directly but has the weakest evidence for cognitive effects and the lowest brain bioavailability of the common choline supplements. Useful for preventing dietary choline deficiency but less effective as a nootropic compared to citicoline or alpha-GPC.

Dietary choline: Eggs (one large egg contains ~147 mg choline), liver, meat, and fish are primary sources. The Adequate Intake for choline is 425–550 mg per day. Most adults get 200–400 mg from food. Citicoline supplementation at 250–500 mg per day meaningfully supplements what diet typically provides.

Safety and Side Effects

Citicoline has a well-established safety record. The 14-trial Cochrane review (PMID 15106147) found citicoline’s adverse effect profile was comparable to placebo in long-term studies spanning up to three years. This is one of the cleaner safety track records in the nootropic category.

Possible side effects at therapeutic doses (uncommon):

• Headache (the most commonly reported)
• Insomnia, particularly with afternoon or evening dosing
• Nausea or mild gastrointestinal upset
• Restlessness or agitation at higher doses (above 1,000 mg/day)

Drug interactions:

• Levodopa (Parkinson’s medication): Citicoline may enhance dopamine transmission. In patients on levodopa, this interaction could theoretically be additive. Use under medical supervision.
• Acetylcholinesterase inhibitors (e.g., donepezil, rivastigmine): Citicoline and these medications both increase acetylcholine activity. Combining them, as in the Alzheimer’s adjunct use case, appears safe based on available trials, but should be supervised by a neurologist.

Who should use caution:

• Individuals with bipolar disorder (elevated dopamine/norepinephrine activity could theoretically exacerbate mania)
• Those on multiple medications affecting the cholinergic system
• Pregnant or breastfeeding women (insufficient safety data, avoid without medical guidance)

Choosing a Citicoline Supplement

First, look for the word “citicoline” or “CDP-choline” on the label. Some products label the ingredient as “Cognizin,” a branded form of citicoline that has been used in several clinical trials. Cognizin is a reliable indicator of the correct compound.

Second, confirm the dose per serving. Many products provide 250 mg per capsule, which aligns with the lower end of the clinical range. Two capsules = 500 mg, a common effective daily dose.

Third, avoid stacking citicoline with high-dose alpha-GPC in the same product. Both significantly elevate choline; combining them at full doses can push acetylcholine activity high enough to cause headaches, brain fog, or nausea, sometimes called “choline headache.” If using both, use lower doses of each.

Fourth, prioritize third-party tested products. NSF Certified for Sport, Informed Sport, or USP Verified testing confirms that the label amount matches the actual content and that the product is free from contamination.

Bottom Line

Citicoline is one of the more evidence-backed nootropics, with Cochrane-reviewed data (PMID 15106147), a decades-long clinical record, and a well-characterized mechanism. For healthy adults, 250–500 mg per day taken in the morning or early afternoon represents the most appropriate dosing range. Older adults targeting verbal memory support may benefit from 1,000 mg per day for at least 12 weeks, consistent with the Spiers et al. trial (PMID 8624220).

Citicoline is not a stimulant and requires consistent daily use to produce measurable effects, expect 4–12 weeks before meaningful cognitive changes, not same-day results. It has an unusually clean safety profile for long-term use.

Related guides:

• ALCAR Dosage: How Much to Take for Cognitive Benefits
• Lion’s Mane Dosage: How Much Should You Take?
• L-Theanine for Sleep: Dosage, Benefits, and Side Effects

Last reviewed: March 28, 2026 by the WHYZ Editorial Team. This article is for informational purposes only and does not constitute medical advice. Consult a healthcare provider before starting any supplement.